On March 5, 2026, the Patented Medicine Prices Review Board (PMPRB or Board) published a series of proposed Practice Directions to streamline its hearing process. The proposed Practice Directions signal an important procedural shift away from live in-person, “action”-style hearings in favour of paper-based “application”-style hearings. This change, to facilitate shorter and less complex hearings, suggests the Board is preparing to hold more enforcement hearings under its new Guidelines process, which just came into force on January 1, 2026. The PMPRB is accepting feedback on the proposed Practice Directions until May 4, 2026.

Read the full publication